Tempus Stock
Cancer battling operating system
About Tempus Stock
Investors
Baillie Gifford
Spotify, Joby Aviation, AUTO1 Group, Ginkgo Bioworks, Carbon, Aurora, Indigo AG, HeartFlow, Tempus, Thumbtack
Franklin Templeton
New Enterprise Associates
Jet, Bloom Energy, Opendoor, Robinhood, Letgo, Databricks, Automation Anywhere, 23andMe, Box, Good Technology
Novo Holdings
Revolution
Tempus, Sweetgreen, Aura, DraftKings, Optoro, BigCommerce, Tala, Uptake Technologies, Scopely, Revolution Foods
T. Rowe Price
Cruise, Airbnb, Rivian, Magic Leap, Deliveroo, Pure Storage, LivingSocial, Cloudera, Ginkgo Bioworks, Toast
Funding History
| September 2015 | $10.0M |
|---|---|
| June 2016 | $10.0M |
| November 2016 | $10.0M |
| April 2017 | $30.0M |
| September 2017 | $70.0M |
| March 2018 | $80.0M |
| August 2018 | $110M |
| May 2019 | $200M |
Management
Founder & Chief Executive Officer
Eric Lefkofsky
Chief Technology Officer
Shane Folley
Chief Operating Officer
Ryan Fukushima
Chief Medical Officer
Gary Palmer
Chief Financial Officer
Vanessa Rollings
Chief Commercial Officer
Mike Yasiejko
Chief Strategy Officer
Marc Yoskowitz
Chief Science Officer
Kevin White
Press
nanalyze - Oct, 29 2019
chicagotribune - Oct, 7 2019
genomeweb - Sep, 30 2019
markets - Sep, 9 2019
chicagotribune - Sep, 6 2019
siliconprairienews - Jun, 17 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Tempus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
